Diagnostic approaches for antibiotic associated diarrhoea

Bulletin, Postgraduate Institute of Medical Education and Research, Chandigarh

Volumn 40, Issue 1, 2006, Pages 4-9

  Vaishnavi, Chetana ^a,b  

^a Department of Gastroenterology ^*  (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Antibiotic associated diarrhoea; Diagnosis

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN; CLINDAMYCIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; LINCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIUM CULTURE; CLOSTRIDIUM DIFFICILE; COUNTER IMMUNOELECTROPHORESIS; DIAGNOSTIC PROCEDURE; DIARRHEA; DISEASE COURSE; DRUG DOSAGE FORM COMPARISON; DRUG EXPOSURE; ENZYME IMMUNOASSAY; EPIDEMIC; HUMAN; INTESTINE FLORA; LATEX AGGLUTINATION TEST; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; PSEUDOMEMBRANOUS COLITIS; RADIODIAGNOSIS; REVIEW; SEROTYPING; TISSUE CULTURE;

EID: 33845976997     PISSN: 03022404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Fekety R and Shah AB. Diagnosis and treatment of Clostridium difficile. JAMA 1993; 269: 71-75.
2. Caeiro J-P, Visnegarwala F and Rodriguez-Barradas MC. Clostridium difficile diarrhoea after use of Tacrolimum following renal transplantation. Clinical Infectious Diseases 1998; 27: 1540.
3. Nanke Y, Kotake S, Akama H, Tomii M, Kamatani N. Pancytopenia and colitis with Clostridium difficile in a rheumatoid arthritis patient taking methotrexate, antibiotics and non-steroidal anti-inflammatory drugs. Clin Rheumatol 2001; 20: 73-75.
4. Kumar B, Vaishnavi C, Sandhu K, Kaur I. Clostridium difficile toxin assay in psoriatic patients. Trop. Gastroenterol. 2004;25:164-167
5. Delmee M and Butts JP. Clostridium difficile associated diarrhoea in children. Management of digestive and liver disorders in infants and children. Elsevier Science Publisher B.V. 1993; 371-379.
6. Katyal R, Vaishnavi C, Singh K. Faecal excretion of brush border membrane enzymes in patients with Clostridium difficile infection. Ind. J. Med. Microbiol 2002; 20: 178-182.
7. Kim KH. Clostridium difficile colitis associated with cancer chemotherapy. Arch. Intern. Med. 1982; 142: 333-335.
8. Panichi G, Pantosti A, Gentile G, Testore GP, Venditti M, Martions P, Serra P. Clostridium difficile colitis in leukemia patients. Eur. J. Cancer Clin. Oncol. 1985; 21: 1159-1163.
9. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N. Engl. J. Med. 1989; 320: 204-210.
10. Silva J Jr., Lessi C. Clostridium difficile as a nosocomial pathogen. J. Hosp. Infect. 1988; 11(Suppl. A): 378-385.
11. Walters BAJ, Roberts R, Stafford R, Seneviratne E. Relapse of antibiotic associated colitis. Endogenous persistence of Clostridium difficile during vancomycin therapy. Med J Australia 1983; 24: 206-212.
12. Heard SR, O'Farell S, Holland D, Crook S, Barnett MJ, Tabaqchali S. The epidemiology of Clostridium difficile with use of typing scheme: nosocomial acquisition and cross-infectio among immunocompromised patients. J. Infect. Dis. 1986; 153: 159-162
13. Starr J. Clostridium difficile associated diarrhoea: diagnosis and treatment. B.M.J. 2005; 3317515): 498-501.
14. Kato H, Kato N, Katow S, Maegawa T, Nakamura S and Lyerly DM. Deletions in the repeating sequences of the toxin A gene of toxin A negative, toxin B-positive Clostridium difficile strains. FEMS Microbiol Lett 1990; 175: 197-203.
15. Alfa MJ, Kabani A, Lyerly DM, Moncrief S, Neville LM, Barrak AA, Harding GKH, Dyck B, Olekson K, and Embil JM. Characterization of a toxin A negative, toxin B positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile associated diarrhoea J. Clin. Microbiol. 2000; 38: 2706-2711.
16. A,B+ strain of Clostridium difficile. J. Clin. Microbiol 2000; 38: 1696-1697.
17. Savidge TC, Pan WH, Newman P, O'Brien M, Auton PM and Pothoulakis C. Clostridium difficile Toxin B is an inflammatory enterotoxin in human intestine. Gastroenterology 2003; 125: 413-420.
18. Drapkin MS, Worthington MG, Chang TW, Razvi SA. Clostridium difficile colitis mimicking acute peritonitis. Arch. Surgery 1985; 120: 1321-1322.
19. Tedesco FJ, Corbess JK, Brownstein RE. Rectal sparing in antibiotic associated pseudomembranous colitis: a prospective study. Gastroenterology 1982; 83: 1259-1260.
20. Mukai JK, Janower ME. Diagnosis of pseudomembranous colitis by computed tomography: a report of two patients. Can. Assoc. Radiol. J. 1987; 38: 62-63.
21. Pudhota SG, Loambiase LR, Vega KJ. Detection of Clostridium difficile pseudomembranous colitis in the absence of diarrhoea with an early use of endoscopy in elderly patients. J. Gen. Intern. Med. 2006; 31: 196.
22. Arroyo LG, Rousseau J, Willey BM, Low DE, Staemptli H, McGeer A, Weese JS. Use of a selective enrichment broth to recover Clostridium difficile from stool swabs stored under different conditions. J. Clin. Microbiol. 2005; 43: 5341-5343.
23. Brazier JS. Role of the laboratory in investigations of Clostridium difficile diarrhoea. Clin. Infect. Dis. 1993; 16(Suppl.4):S228-233
24. Peterson LR, Kelly PJ, Nordbrock HA. Role of culture and toxin detection in laboratory testing for diagnosis of Clostridium difficile associated diarrhoea. Eur. J. Clin. Microbiol. Infect. Dis. 1996; 15: 330-336.
25. Ayyagari A, Sharma P, Venkateswarlu, Mehta S, Agarwal KC. Prevalence of Clostridium difficile in pseudomembranous and antibiotic associated colitis in North India. Indian J. Gastroenterol 1986; 4: 157-160.
26. Kochhar R, Ayyagari A, Goenka MK, Dhall GK, Aggarwal R, Mehta SK. Role of infectious agents in exacerbation of ulcerative colitis in India. A study of Clostridium difficile. J. Clin. Gastroenterol. 1993; 16: 26-30.
27. Woods GL, Iwen PC, Comparison of a dot immunobinding assay, latex agglutination and cytotoxin assay for laboratory diagnosis of Clostridium difficile associated diarrhea. J. Clin. Microbiol. 1990; 28: 855-857.
28. Mohan SS, McDermott BP, Parchuri S, Cunha BA. Lack of value of repeat stool testing for Clostridium difficile toxin. Am. J. Med. 2006; 119: 356.
29. Lyerly DM, Barrosa LA, Wilkins TD. Identification of the latex test reactive protein of Clostridium difficile as glutamate dehydrogenase. J. Clin. Microbiol. 1991; 29: 2639-2642.
30. Van den Berg RJ, Bruijnesteijn van Coppenraet LS, Gerrisen HJ, Endtz HP, van den Vorm ER, Kuijper EJ. Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile-associated diarrhoea in hospitalized patients. J. Clin. Microbiol. 2005; 43: 5338-5340.
31. Kato H, Yokoyama T, Kato H and Arakawa Y. Rapid and simple method for detecting the toxin B gene of Clostridium difficile in stool specimens by loop mediated isothemal amplication. 2005.
32. Vaishnavi C, Kochhar R, Bhasin DK, Thapa BR, and Singh K. Detection of Clostridium difficile toxin by an indigenously developed latex agglutination assay. Trop. Gastroenterol. 1999; 20: 33-35.
33. Vaishnavi C, Kochhar R, Bhasin DK, Thapa BR and Singh K. Faecal lactoferrin latex agglutination assay for Clostridium difficile associated intestinal diseases. Indian J. Med. Microbiol. 1998; 16: 81-83.
34. Vaishnavi C, Bhasin DK, Singh K. Faecal lactoferrin assay as a cost effective tool for intestinal inflammation. Am. J. Gastroenterol. 2000; 95: 3002.
35. Vaishnavi C, Bhasin DK, Kochhar R, Singh K. Clostridium difficile toxin and faecal lactoferrin assays in adult patients. Microbes and Infection 2000; 2: 1827-1830.
36. Vaishnavi C, Thapa BR, Thennarasu K and Singh K. Faecal lactoferrin assay as an adjunct to Clostridium difficile diarrhoea. Ind. J. Pathol. Mcirobiol. 2002; 45: 69-74.
37. Vaishnavi C, Kochhar R, Bhasin DK, Thennarasu K, Singh K. Simultaneous assays for Clostridium difficile and faecal lactoferrin in ulcerative colitis. Trop. Gastroenterology 2003; 24: 13-16.